These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29407555)

  • 21. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
    Al Shuwaili AH; Rasool BK; Abdulrasool AA
    Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment.
    Albash R; El-Nabarawi MA; Refai H; Abdelbary AA
    Int J Nanomedicine; 2019; 14():6555-6574. PubMed ID: 31616143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.
    Ma M; Wang J; Guo F; Lei M; Tan F; Li N
    J Mater Sci Mater Med; 2015 Jun; 26(6):191. PubMed ID: 25989936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization.
    Shamma RN; Elsayed I
    J Liposome Res; 2013 Sep; 23(3):244-54. PubMed ID: 23713516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size.
    Fahmy AM; El-Setouhy DA; Habib BA; Tayel SA
    AAPS PharmSciTech; 2019 Jan; 20(3):95. PubMed ID: 30694404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
    Gajra B; Patel RR; Dalwadi C
    Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
    Elsherif NI; Shamma RN; Abdelbary G
    AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced Permeation of Methotrexate via Loading into Ultra-permeable Niosomal Vesicles: Fabrication, Statistical Optimization, Ex Vivo Studies, and In Vivo Skin Deposition and Tolerability.
    Al-Mahallawi AM; Fares AR; Abd-Elsalam WH
    AAPS PharmSciTech; 2019 Apr; 20(5):171. PubMed ID: 31004239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations.
    Shreya AB; Managuli RS; Menon J; Kondapalli L; Hegde AR; Avadhani K; Shetty PK; Amirthalingam M; Kalthur G; Mutalik S
    J Liposome Res; 2016 Sep; 26(3):221-32. PubMed ID: 26621370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Optimization and Characterization of Granisetron HCl Loaded Nano-gel for Transdermal Delivery.
    Aggarwal G; Kumar V; Chaudhary H
    Pharm Nanotechnol; 2017; 5(4):317-328. PubMed ID: 28925887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology.
    Swain K; Pattnaik S; Sahu SC; Patnaik KK; Mallick S
    J Drug Target; 2010 Feb; 18(2):106-14. PubMed ID: 19712026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation.
    Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI
    AAPS PharmSciTech; 2017 Nov; 18(8):2898-2909. PubMed ID: 28429293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation of Nanospanlastics as a Promising Approach for ‎Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-‎Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro ‎Characterization, and ex vivo Permeation Study.
    Badria F; Mazyed E
    Drug Des Devel Ther; 2020; 14():3697-3721. PubMed ID: 32982176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole:
    Nemr AA; El-Mahrouk GM; Badie HA
    J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on ethosomes as mode for transdermal delivery of an antidiabetic drug.
    Bodade SS; Shaikh KS; Kamble MS; Chaudhari PD
    Drug Deliv; 2013; 20(1):40-6. PubMed ID: 23311652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A statistical approach to the development of a transdermal delivery system for ondansetron.
    Obata Y; Ashitaka Y; Kikuchi S; Isowa K; Takayama K
    Int J Pharm; 2010 Oct; 399(1-2):87-93. PubMed ID: 20705125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.